MRC1 and Lynch syndrome: As next-generation sequencing (NGS) becomes more widely adopted for precision oncology and diagnostic purposes, the ability to accurately determine MSI-H/dMMR status [21,22] and identify MMR gene somatic mutations/LOH [23] using this methodology is becoming increasingly attractive as a streamlined approach to diagnosing Lynch syndrome.